Evidence map›Paper›PMID 40723230›Full record

ArticleCancers2025

Fluorescent In Situ Hybridization Testing Allows the Diagnosis of

Clara Bastard, Charline Caumont, Laura Samaison, Isabelle Quintin-Roué, Laurent Doucet, Pascale Marcorelles, Cédric Le Maréchal, Jean-Philippe Merlio, David Cappellen, Arnaud Uguen

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Clara BastardCHU Brest, Service d'Anatomie et Cytologie Pathologiques, F-29200 Brest, France.
Charline CaumontCHU Bordeaux, Department of Tumor Biology, F-33600 Pessac, France.ORCID 0000-0002-0352-5406
Laura SamaisonOuest Pathologie, F-29000 Quimper, France.
Isabelle Quintin-RouéCHU Brest, Service d'Anatomie et Cytologie Pathologiques, F-29200 Brest, France.
Laurent DoucetCHU Brest, Service d'Anatomie et Cytologie Pathologiques, F-29200 Brest, France.
Pascale MarcorellesCHU Brest, Service d'Anatomie et Cytologie Pathologiques, F-29200 Brest, France.
Cédric Le MaréchalCHU Brest, Service de Génétique Moléculaire, F-29200 Brest, France.
Jean-Philippe MerlioCHU Bordeaux, Department of Tumor Biology, F-33600 Pessac, France.ORCID 0000-0002-0305-0850
David CappellenCHU Bordeaux, Department of Tumor Biology, F-33600 Pessac, France.
Arnaud UguenCHU Brest, Service d'Anatomie et Cytologie Pathologiques, F-29200 Brest, France.ORCID 0000-0002-0230-2905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some pancreatic ductal-type (PDADK) and lung adenocarcinomas (LADK) lacking other molecular drivers are reported to harbor

Indexed as

fluorescent in situ hybridizationlung cancerNRG1 fusionpancreatic cancerRNA-sequencing

Identifiers

PMID40723230
PMCPMC12294116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.